Australia to review gene patents (full version)
24 November 2008
Peter Ollier, Hong Kong
Australia’s Senate launched an enquiry into the impact of granting gene patents in the country on November 19
The move comes after Australian company Genetic Technologies tried to enforce its exclusive licence to use patents owned by Myriad Genetics to test for the BRCA1 and BRCA2 genes. These genes increase the chances of breast cancer.
After widespread criticism in the media that the move would lead to fewer tests for the genes being carried out and possible...
Only subscribers have complete access to Managing IP Magazine,
log in or
subscribe now.
Alternatively take a
free trial, giving you 48-hour access to Managing IP Magazine (some articles and surveys may be excluded).
Subscribe Now
This article is available to subscribers. Please click subscribe to read the rest of the article.
Subscribe
Take a free trial
Please take a free 48-hour trial to gain limited access. Some articles and surveys may be excluded.
Take a free trial